Preliminary results of concurrent chemoradiotherapy with IMRT for stage III-IV oropharyngeal cancer

K. Shirai, J. Saitoh, M. Kawashima, Y. Takakusagi, S. Shiba, A. Musha, K. Fukata, T. Ohno, T. Nakano, Y. Takayasu, K. Takahashi, K. Chikamatsu

Research output: Contribution to journalArticle

Abstract

Between 2011 and 2013, concurrent chemoradiotherapy with IMRT was performed for 11 advanced oropharyngeal cancer patients and median follow-up was 11 months. The local-regional failure was not observed. Acute incidence of grade 2 xerostomia was 7 patients (64%). After 6 and 12 months, grade 2 xerostomia was 11% and 0%, respectively. Further follow-up was required to evaluate local control and the late adverse events after IMRT.

Original languageEnglish
Pages (from-to)1357-1364
Number of pages8
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number10
Publication statusPublished - 2014 Oct 1
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Shirai, K., Saitoh, J., Kawashima, M., Takakusagi, Y., Shiba, S., Musha, A., Fukata, K., Ohno, T., Nakano, T., Takayasu, Y., Takahashi, K., & Chikamatsu, K. (2014). Preliminary results of concurrent chemoradiotherapy with IMRT for stage III-IV oropharyngeal cancer. Japanese Journal of Clinical Radiology, 59(10), 1357-1364.